Luteaalfaasi

Luteaalfaasi, also known as luteal phase deficiency or luteal phase failure, is a reproductive health condition characterized by insufficient function or lifespan of the corpus luteum during the menstrual cycle. The corpus luteum is a temporary endocrine structure that forms in the ovary after ovulation and produces progesterone, a hormone essential for maintaining early pregnancy. When luteaalfaasi occurs, progesterone levels may be too low to support implantation or sustain pregnancy, potentially leading to infertility or recurrent miscarriage.

This condition can arise from various factors, including hormonal imbalances, inadequate luteal phase formation, or abnormal ovarian function. Symptoms may be subtle or absent, but it is often diagnosed in women experiencing unexplained infertility or repeated pregnancy loss. Diagnostic measures typically involve tracking hormone levels throughout the menstrual cycle, particularly progesterone, and using ultrasound to observe corpus luteum development.

Treatment approaches aim to correct hormonal deficiencies and may include progesterone supplementation, either through pills, vaginal creams, or injections. Addressing underlying causes, such as thyroid or hormonal disorders, also plays a critical role in management. In some cases, lifestyle modifications and addressing factors like stress or weight irregularities may improve outcomes.

Research on luteaalfaasi continues, with ongoing studies exploring its exact mechanisms and more effective treatments. Although it is one of several factors influencing female fertility, prompt diagnosis and targeted therapy can significantly enhance the chances of conception and pregnancy maintenance for affected women.